05/31/23 9:00 AMNasdaq : GOVX, GOVXW partnershipGeoVax Partners With ABL to Advance cGMP Production of Vaccine Candidatesvia NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced it has executed a Master Services Agreement (MSA) with Advanced BioscienceRHEA-AIneutral
05/25/23 9:00 AMNasdaq : GOVX, GOVXW conferencesGeoVax to Participate in Upcoming Industry MeetingsGeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, announcedRHEA-AIneutral
05/24/23 8:00 AMNasdaq : GOVX, GOVXW covid-19GeoVax’s Next-Generation COVID-19 Vaccine Shows High Immunogenicity in Immunocompromised Patientsvia NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines againstRHEA-AIneutral
05/15/23 9:00 AMNasdaq : GOVX, GOVXW conferencescovid-19GeoVax Next-Generation COVID-19 Vaccine Data to be Presented at Two Upcoming Scientific Meetingsvia NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectiousRHEA-AIneutral
05/09/23 9:00 AMNasdaq : GOVX, GOVXW conferencesGeoVax Labs to Participate in A.G.P.’s Virtual Healthcare Conferencevia NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that it will participate in the Alliance Global Partners’ Virtual HealthcareRHEA-AIneutral
05/04/23 4:00 PMNasdaq : GOVX, GOVXW earningsGeoVax Reports 2023 First Quarter Financial Results and Provides Corporate Updatevia NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology companyRHEA-AIneutral
04/26/23 9:00 AMNasdaq : GOVX, GOVXW conferencesGeoVax to Participate in the 4th Symposium on Infectious Diseases in the Immunocompromised Hostvia NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing vaccines and immunotherapies against cancers and infectious diseases, today announced its participation in and sponsor support of the 4th Symposium on InfectiousRHEA-AIneutral
04/25/23 9:00 AMNasdaq : GOVX, GOVXW conferencesearningsGeoVax to Host First Quarter 2023 Business Update and Financial Results Conference Call on May 4, 2023via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, announced today that it will report first quarter 2023 financial results onRHEA-AIneutral
04/17/23 9:00 AMNasdaq : GOVX, GOVXW covid-19GeoVax Announces Expansion of Next-Generation COVID-19 Vaccine Rights to Include Omicron Variants and Use Against OrthopoxvirusesGeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases,RHEA-AIneutral
04/06/23 10:00 AMNasdaq : GOVX, GOVXW clinical trialcovid-19GeoVax Announces Presentation of Preliminary Data from Clinical Trial of Next-Generation COVID-19 Vaccine Candidatevia NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines againstRHEA-AIneutral
